Show simple item record

dc.contributor.authorSathe, Kinnari
dc.contributor.authorMaetzler, Walter
dc.contributor.authorLang, Johannes
dc.contributor.authorMounsey, Ross Brian
dc.contributor.authorFleckenstein, Corinna
dc.contributor.authorMartin, Heather Louise
dc.contributor.authorSchulte, Claudia
dc.contributor.authorMustafa, Sarah
dc.contributor.authorSynofzik, Matthis
dc.contributor.authorVukovic, Zvonimir
dc.contributor.authorItohara, Shigeyoshi
dc.contributor.authorBerg, Daniela
dc.contributor.authorTeismann, Peter
dc.date.accessioned2013-04-04T15:35:05Z
dc.date.available2013-04-04T15:35:05Z
dc.date.issued2012-11
dc.identifier19871852
dc.identifierd379c263-7b2a-45dc-b7f6-aafe8920bfe3
dc.identifier84870168829
dc.identifier.citationSathe , K , Maetzler , W , Lang , J , Mounsey , R B , Fleckenstein , C , Martin , H L , Schulte , C , Mustafa , S , Synofzik , M , Vukovic , Z , Itohara , S , Berg , D & Teismann , P 2012 , ' S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway ' , Brain , vol. 135 , no. 11 , pp. 3336-3347 . https://doi.org/10.1093/brain/aws250en
dc.identifier.issn0006-8950
dc.identifier.urihttp://hdl.handle.net/2164/2763
dc.format.extent12
dc.format.extent1278729
dc.language.isoeng
dc.relation.ispartofBrainen
dc.subjectcalcium-binding proteinen
dc.subjectMPTPen
dc.subjectParkinson's diseaseen
dc.subjectS100Ben
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleS100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathwayen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1093/brain/aws250


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record